- Fund Type: Closed-End Fund
- Objective: Sector Fund-Health & Biotech
- Asset Class: Equity
- Geographic Focus: U.S.
BlackRock Health Sciences Trust
+ Add to WatchlistXBMEX:US
32.48 USD 0.17 0.53%As of 09:29:30 ET on 05/21/2013.
Snapshot for BlackRock Health Sciences Trust (XBMEX)
| Year To Date: | +17.96% | 3-Month: | +10.85% | 3-Year: | +17.49% | 52-Week Range: | 25.44 - 32.75 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +1.88% | 1-Year: | +31.40% | 5-Year: | +12.12% | Beta vs SPX: | 0.80 |
Fund Profile & Information for XBMEX
Blackrock Health Sciences Trust is a non-diversified, closed-end management investment company incorporated in the USA. The Fund's objective is to provide total return through a combination of current income and capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.
| Inception Date: | 03-28-2005 | Telephone: | 1-800-882-0052 |
|---|---|---|---|
| Managers: | H ERIN XIE / KYLE G MCCLEMENTS | ||
| Web Site: | www.blackrock.com | ||
Fundamentals for XBMEX
| NAV | (on 2013-05-21) 32.48 |
|---|---|
| Assets (M) | (on 2012-12-31) 214.90 |
| Fund Leveraged | N |
| Minimum Investment | 0.00 |
| Minimum Subsequent Investment | 0.00 |
Dividends for XBMEX
| Dividend Type | Income |
|---|---|
| Dividend Frequency | Quarter |
| Last Dividend Net | (on 2013-03-13) 0.38 |
| Dividend Yield (ttm) | 7.35 |
Fees & Expenses for XBMEX
| Front Load | 0.00 |
|---|---|
| Back Load | 0.00 |
| Current Mgmt Fee | 1.00 |
| Redemption Fee | 0.00 |
| 12b1 Fee | 0.00 |
| Expense Ratio | 1.13 |
Top Fund Holdings for XBMEX
Filing Date: 03/31/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Pfizer Inc | 384,900 | 11,108,214 | 4.589% |
| Gilead Sciences Inc | 222,121 | 10,868,381 | 4.490% |
| Johnson & Johnson | 131,970 | 10,759,514 | 4.445% |
| Roche Holding AG | 41,800 | 9,744,548 | 4.025% |
| Novartis AG | 130,800 | 9,322,373 | 3.851% |
| Celgene Corp | 80,274 | 9,304,559 | 3.844% |
| Amgen Inc | 83,600 | 8,569,836 | 3.540% |
| Eli Lilly & Co | 144,000 | 8,177,760 | 3.378% |
| Bristol-Myers Squibb Co | 193,800 | 7,982,622 | 3.298% |
| Sanofi | 71,800 | 7,322,571 | 3.025% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page